Biosimilar therapeutic agents: issues with bioequivalence and immunogenicity

H. Schellekens

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)797-799
Number of pages3
JournalEuropean Journal of Clinical Investment
Volume34
Issue number12
Publication statusPublished - 2004

Cite this